Gastrointestinal Stromal Tumor Market Analysis With Opportunity Segments For 2024-2033

Gastrointestinal Stromal Tumor Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

The Business Research Company’s Gastrointestinal Stromal Tumor Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

LONDON, GREATER LONDON, UK, August 2, 2024 /EINPresswire.com/ -- The gastrointestinal stromal tumor market has experienced robust growth in recent years, expanding from $1.18 billion in 2023 to $1.28 billion in 2024 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increased awareness and early diagnosis, emergence of targeted therapies, enhanced surgical techniques, development of personalized medicine, improvements in supportive care.

Strong Future Growth Anticipated
The gastrointestinal stromal tumor market is projected to continue its strong growth, reaching $1.69 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to continued research and drug development, rise in patient-centric healthcare, integration of precision medicine in clinical practice, increasing access to targeted therapies, expanding genomic profiling capabilities.

Explore Comprehensive Insights Into The Global Gastrointestinal Stromal Tumor Market With A Detailed Sample Report:
https://www.thebusinessresearchcompany.com/sample_request?id=13248&type=smp

Growth Driver Of The Gastrointestinal Stromal Tumor Market
The growing incidence of stomach cancer is expected to propel the growth of the gastrointestinal stromal tumor market going forward. Stomach cancer refers to the uncontrolled growth and multiplication of malignant cells in the lining of the stomach. while gastrointestinal stromal tumors (GISTs) can occur in the stomach, they are distinct from stomach cancer. When two separate tumors collide and merge into one, patients with GISTs have been found to have an increased risk of developing additional cancers, including small bowel adenocarcinoma.

Explore The Report Store To Make A Direct Purchase Of The Report:
https://www.thebusinessresearchcompany.com/report/gastrointestinal-stromal-tumor-global-market-report

Major Players And Market Trends
Key players in the gastrointestinal stromal tumor market include Pfizer Inc., F. Hoffmann-La Roche AG, Bayer AG, Novartis AG, Merck & Co. Inc., GlaxoSmithKline PLC, Bristol-Myers Squibb Company.

Major companies operating in the gastrointestinal stromal tumor market are innovating new drugs such as QINLOCK (Ripretinib) to meet larger customer bases, more sales, and increased revenue. QINLOCK (Ripretinib) is a prescription medicine used to treat advanced gastrointestinal stromal tumor (GIST).

Gastrointestinal Stromal Tumor Market Segments:
1) By Treatment Type: Chemotherapy, Targeted Therapy, Other Treatment Types
2) By Indication: Stomach, Small Intestine, Others Indications
3) By End-User: Hospitals, Clinics, Specialized Cancer Treatment Centers, Other End-Users

Geographical Insights: North America Leading The Market
North America was the largest region in the gastrointestinal stromal tumor market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal stromal tumor market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Gastrointestinal Stromal Tumor Market Definition
A gastrointestinal stromal tumor (GIST) is a type of rare, non-epithelial tumor that originates in the gastrointestinal (GI) tract. These are most commonly developed in the stomach or the small intestine, but they can occur anywhere along the GI tract, from the esophagus to the rectum.

Gastrointestinal Stromal Tumor Global Market Report 2024 from The Business Research Company covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.

The Gastrointestinal Stromal Tumor Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on gastrointestinal stromal tumor market size, gastrointestinal stromal tumor market drivers and trends, gastrointestinal stromal tumor market major players, gastrointestinal stromal tumor competitors' revenues, gastrointestinal stromal tumor market positioning, and gastrointestinal stromal tumor market growth across geographies. The gastrointestinal stromal tumor market report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:

Tumor Ablation Therapy Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/tumor-ablation-therapy-devices-global-market-report

Tumor Embolization Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report

Cancer Tumor Profiling Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.